Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon

Table 4 MLL2 expression and clinicopathological variables in breast cancer (n = 96)

	Number of cases positive for cytoplasmic MLL2	Number of positive cases where T > B (%)
N	96	86 (90)
Tumor stage
Early (1 & 2)	81	75 (93)*
Advanced (3 & 4)	15	11 (73)
Menopausal status
Pre	20	16 (80)
Post	76	70 (92)**

Clinicopathological variables associated with elevated levels of cytoplasmic MLL2 immunoreactivity in patients with invasive breast cancer; *p = 0.02; **p = 0.03

ISSN: 1475-2867